2. Drugs
  3. Human OTC Drug
  4. Walgreens Stye Eye Relief

Walgreens Stye Eye Relief

Graphite, Sulfur, Conium Maculatum


Similasan Ag
Human Otc Drug
NDC 53799-404
Walgreens Stye Eye Relief also known as Graphite, Sulfur, Conium Maculatum is a human otc drug labeled by 'Similasan Ag'. National Drug Code (NDC) number for Walgreens Stye Eye Relief is 53799-404. This drug is available in dosage form of Solution/ Drops. The names of the active, medicinal ingredients in Walgreens Stye Eye Relief drug includes Conium Maculatum Flowering Top - 6 [hp_C]/10mL Graphite - 12 [hp_C]/10mL Sulfur - 12 [hp_C]/10mL . The currest status of Walgreens Stye Eye Relief drug is Active.

Drug Information:

Drug NDC: 53799-404
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Walgreens Stye Eye Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Graphite, Sulfur, Conium Maculatum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Similasan Ag
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution/ Drops
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CONIUM MACULATUM FLOWERING TOP - 6 [hp_C]/10mL
GRAPHITE - 12 [hp_C]/10mL
SULFUR - 12 [hp_C]/10mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:OPHTHALMIC
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jun, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Similasan AG
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:Q28R5GF371
4QQN74LH4O
70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
53799-404-111 BOTTLE, DROPPER in 1 CARTON (53799-404-11) / 10 mL in 1 BOTTLE, DROPPER01 Jun, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.
Other medicines with the same generic name

Walgreens Stye Eye Relief


Graphite, Sulfur, Conium Maculatum

Solution/ Drops
Similasan AG
NDC: 53799-404

Purpose:

Purpose redness eyelid redness tearing, burning

Product Elements:

Walgreens stye eye relief graphite, sulfur, conium maculatum conium maculatum flowering top conium maculatum flowering top graphite graphite sulfur sulfur water silver sulfate sodium nitrate

Indications and Usage:

Uses* according to homeopathic principles, the active ingredients in this product temporarily relieve minor symptoms such as: • redness • burning • eyelid redness • tearing

Warnings:

Warnings •the purpose of this product is to provide temporary relief of stye symptoms, and is not a cure for styes. • for external use only. • according to homeopathic principles, symptoms may temporarily worsen before improving (initial exacerbation of symptoms). • to avoid contamination do not touch the tip of the bottle to any surface. • to avoid contamination use within 30 days of opening. expiration date only refers to unopened bottle. • contact wearers: consult a physician prior to using. if pregnant, trying to get pregnant or breast feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. do not use: • if the solution changes color or becomes cloudy • if condition is accompanied by fever stop use and ask a doctor if: • you experience eye pain or changes in vision • symptoms worsen or persist for more than 72 hours • the stye en
larges • the stye opens, draining discharge or pus into the eye

Do Not Use:

Warnings •the purpose of this product is to provide temporary relief of stye symptoms, and is not a cure for styes. • for external use only. • according to homeopathic principles, symptoms may temporarily worsen before improving (initial exacerbation of symptoms). • to avoid contamination do not touch the tip of the bottle to any surface. • to avoid contamination use within 30 days of opening. expiration date only refers to unopened bottle. • contact wearers: consult a physician prior to using. if pregnant, trying to get pregnant or breast feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. do not use: • if the solution changes color or becomes cloudy • if condition is accompanied by fever stop use and ask a doctor if: • you experience eye pain or changes in vision • symptoms worsen or persist for more than 72 hours • the stye enlarges • the stye opens, draining discharge or pus into the eye

Dosage and Administration:

Directions for adults and children age 2 and over: • remove tamper evident seal from neck of bottle • twist cap off bottle • don't squeeze bottle, squeeze plastic tip to release 2 to 3 drops into eye • apply 3-4 times per day • replace cap after use • if desired, use with a warm, moistened washcloth placed directly on eyelid

Stop Use:

Stop use and ask a doctor if: • you experience eye pain or changes in vision • symptoms worsen or persist for more than 72 hours • the stye enlarges • the stye opens, draining discharge or pus into the eye

Package Label Principal Display Panel:

Principal display panel stye eye drops 0.33 fl oz (10 ml) principal display panel stye eye drops 0.33 fl oz (10 ml)

Further Questions:

Questions? 1-800-925-4733 ++this product is not distributed by similasan ag, owner of the registered trademark similasan®. *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. for your protection do not use if tamper evident seal around neck is missing or broken


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.

Pharmacy also called "drugstore" is a retail shop which provides prescription drugs, among other products. At the pharmacy, a pharmacist oversees the fulfillment of medical prescriptions and is available to give advice on their offerings of over-the-counter drugs. But pharmacy is not just about filling prescriptions. It is also about promoting health awareness and contributing to the betterment of the community. Pharmacists may:
  • Prepare or supervise the dispensing of medicines, ointments and tablets.
  • Advise patients on how their medicines are to be taken or used in the safest and most effective way in the treatment of common ailments.
  • Select, give advice on and supply non-prescription medicine, sickroom supplies and other products.
  • Develop legally recognised standards, and advise on government controls and regulations concerning the manufacture and supply of medicines.
  • Work in the research and development of medicines and other health-related products.
  • Be involved in the management of pharmaceutical companies.
  • Advise members of the public and other health professionals about medicines (both prescription and over-the-counter medicines), including appropriate selection, dosage and drug interactions, potential side effects and therapeutic effects.
© PharmacyGPS 2025
Disclaimer
Privacy Policy